“ab fubinaca”的搜索结果

8 个项目

每页

设置降序顺序
  1. Talazoparib tosylate

    Catalog No. A20238
    Quick View
    PARP1/2 inhibitor
    Talazoparib tosylate (BMN 673ts) is a novel, potent and orally available PARP1/2 inhibitor with an IC50 of 0.57 nM for PARP1. 了解更多
  2. GeA-69

    Catalog No. A19705
    Quick View
    PARP14 inhibitor
    GeA-69 is a selective, highly cell permeable allosteric inhibitor of poly-adenosine-diphosphate-ribose polymerase 14 (PARP14) targeting macrodomain 2, with a Kd of 2.1 ?M. 了解更多
  3. NMS-P118

    Catalog No. A20994
    Quick View
    PARP-1 Inhibitor
    NMS-P118 is a potent, orally available, and highly selective PARP-1 Inhibitor for cancer therapy. 了解更多
  4. Veliparib dihydrochloride

    Catalog No. A21356
    Quick View
    PARP inhibitor
    Veliparib dihydrochloride is a potent PARP inhibitor, inhibiting PARP1 and PARP2 with Kis of 5.2 and 2.9 nM, respectively. 了解更多
  5. Niraparib hydrochloride

    Catalog No. A18018
    Quick View
    PARP1 and PARP2 inhibitor
    Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. 了解更多
  6. Niraparib tosylate

    Catalog No. A16618
    Quick View
    PARP1/PARP2 inhibitor
    Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. 了解更多
  7. 3-Aminobenzamide

    Catalog No. A10475
    Quick View
    PARP 抑制剂
    3-Aminobenzamide是一种新型PARP抑制剂,已知它通过抑制DNA损伤的修复使细胞在体外对辐射敏感。 了解更多
  8. ABT-888 (Veliparib)

    Catalog No. A10026
    Quick View
    PARP 抑制剂
    ABT-888 (Veliparib)是一种潜在的抗癌药物,可作为PARP抑制剂。 了解更多

8 个项目

每页

设置降序顺序
Rewards